INMB
Closed
Inmune Bio Inc
2.09
-0.22 (-9.52%)
Last Update: 01 Jul 2025 23:19:00
Yesterday: 2.31
Day's Range: 1.89 - 2.22
Send
sign up or login to leave a comment!
When Written:
6.915
INmune Bio Inc is a clinical-stage biotechnology company that focuses on developing immunotherapies for the treatment of cancer and other diseases. The company's lead product candidate, INB03, is a novel biologic drug that targets a specific immune checkpoint molecule called CD47, which is overexpressed on many cancer cells and allows them to evade the immune system. INmune Bio is also developing a pipeline of other immunotherapies that target various aspects of the immune system, including cytokines, chemokines, and immune cells. The company was founded in 2015 and is headquartered in La Jolla, California.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








